The role of omega-3 fatty acids in the management of rotator cuff tendinopathy.

Not Applicable

Completed

• Conditions: Rotator cuff tendinopathy; Musculoskeletal Diseases

• Registration Number: ISRCTN17856844
• Lead Sponsor: Guy's and St Thomas' NHS Foundation Trust

Brief Summary

2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30364577 (added 27/11/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2012-12-12
• Study Start: 2015-06-05
• Last Update Posted: 6 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

The study aimed to recruit men and women aged 18 to 80 years, who were referred for physiotherapy to one of four physiotherapy departments with a diagnosis of unilateral RC tendinopathy.
1. Unilateral shoulder pain of more than 3 months duration (anterior &/or antero-lateral
2. Pain produced or increased during flexion and/or abduction of the symptomatic shoulder
3. Failure of conservative management (manual therapy, exercises, injections, electrotherapy NSAIDS)
4. At least 4 of the following:
4.1 Positive Neer’s impingement sign
4.2 Positive Hawkins & Kennedy test
4.3 Pain & weakness reproduced on full & empty can test
4.4 Pain & weakness on resisted shoulder external rotation
4.5 Pain on palpation over greater tuberosity of humerus

Exclusion Criteria

1. Outside age range of 18-80 years
2. Known allergy to fish or fish products
3. Unwilling to take fish oils
4. Currently taking high dose fish oils (over 1g daily).
5. Diabetes
6. Pregnancy or breast feeding
7. Reproduction of shoulder symptoms during active cervical spine movements
8. Post traumatic onset of symptoms
9. Radiographic or clinical evidence of shoulder instability (sulcus, anterior/posterior draw, relocation test, apprehension test)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The Oxford shoulder score questionnaire was used at baseline, 2 months, 3 months, 6 months and 12 months.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Numerical rating score for pain<br> 2. Shoulder Pain and Disability Index (SPADI)<br> 3. Patient specific functional score (PSFS): a questionnaire used to quantify activity limitation and measure functional outcome in areas chosen by the patient specifically<br> 4. EuroQol D5-3L (EQ-D5-3L) health questionnaire: a measure of health related quality of life<br> 5. Short Form (SF)-36<br> 6. Global perception of change<br> 7. Range of glenohumeral range of motion (flexion/abduction/internal and external rotation, hand behind back)<br> 8. Shoulder strength (shoulder flexion/abduction/internal and external rotation and biceps strength).<br><br> All taken at baseline, 2 months, 3 months, 6 months and 12 months.<br>